Company: CXDO
Filing Date: 2025-03-04
Form Type: 10-K
Source: 0001654954-25-002287
Chunk: 365

Company: Crexendo, Inc.
Filing Date: 2025-03-04
Form: 10-K
Item: Item 1A
Chunk 365
---
1,293   1,328   1,822 Cost of product revenue  839   881   923   688 Selling and marketing  3,809   3,613   3,502   3,747 General and administrative   3,997   3,167   3,309   3,320 Research and development  1,191   1,138   1,275   1,255 Total operating expenses  14,065   13,187   13,510   14,126 Income/(loss) from operations  (1,574)  (517)  364   38 Total other income/(expense), net  16   (4)  1,373   40 Income/(loss) before income tax  (1,558)  (521)  1,737   78 Income tax benefit/(provision)  (24)  (24)  (33)  (17)Net income/(loss) $(1,582) $(545) $1,704  $61                  Basic earnings per common share (1) $(0.06) $(0.02) $0.07  $0.00 Diluted earnings per common share (1) $(0.06) $(0.02) $0.06  $0.00 ______________________(1)Earnings per common share is computed independently for each of the quarters presented. Therefore, the sums of quarterly earnings per common share amounts do not necessarily equal the total for the twelve-month periods presented.

 82Table of Contents

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13(a)-15(b) under the Exchange Act, as the end of the period covered by this annual report on Form 10-K.

Based on this evaluation, our chief executive officer and chief financial officer concluded that, as of December 31, 2024 our disclosure controls and procedures